Home » Newsletters » BioWorld Science

BioWorld Science

June 20, 2017

View Archived Issues

Novel pocket-modified vancomycin analogues show potential as durable and potent antibiotics

Mutations in SCN9A gene linked to diabetic neuropathic pain

FDA accepts Rigel Pharmaceuticals' NDA for fostamatinib disodium

Axovant Sciences' nelotanserin obtains FDA fast track designation

Seattle Genetics halting phase III CASCADE study of vadastuximab talirine

Human umbilical cord mesenchymal stem cells evaluated in ischemic cardiomyopathy trial

EC approves biosimilar rituximab from Sandoz

Next generation diarylquinoline TBAJ-587 displays superior potency against tuberculosis

MedImmune introduces a novel anti-FcRII-a antibody

Engineered grafts show esophageal regeneration ability in a large animal model

Tessa Therapeutics enters alliance with Parker Institute for Cancer Immunotherapy

Cell Medica acquires Catapult Therapy TCR

Abide Therapeutics describes novel MGL/FAAH inhibitors

FDA approves Baxdela for ABSSSI

eFFECTOR Therapeutics identifies new MAP kinase signal-integrating kinase 1/2 inhibitors

Novel USP1 inhibitors identified at FORMA Therapeutics

Clovis Oncology presents positive topline data from phase III ARIEL3 study of rucaparib

ViiV Healthcare presents novel anti-HIV compounds

AstraZeneca, Cancer Research Technology patent GLS inhibitors

Narurapid and Narusus launched in Japan

Enzychem Lifesciences begins phase II trial of EC-18 in CIN

Novartis reports phase III data on RTH-258 in neovascular AMD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...